20 articles tagged with "pharmaceuticals"
The Trump administration has announced a 100% tariff on imported brand-name drugs, with significant caveats that may influence future trade negotiations.
The EPA's recent proposal to classify microplastics and pharmaceuticals as contaminants in drinking water marks a significant regulatory shift that could affect water treatment processes.
The Trump administration is negotiating new drug-pricing agreements with smaller pharmaceutical companies, influenced by potential tariffs.
The EPA's recent identification of microplastics and pharmaceuticals as drinking water contaminants raises significant concerns about water quality and public health.
Johnson & Johnson (JNJ) demonstrates a strong growth pipeline and solid performance across key therapeutic areas, indicating a positive trajectory for future revenue.
Doctors Without Borders has criticized Gilead Sciences for declining to provide lenacapavir, a crucial HIV prevention drug, after lengthy negotiations.
The White House has initiated discussions on drug pricing reforms by sharing drafted legislative text with major pharmaceutical companies, while also addressing Chinese biotech licensing.
Research into protein dynamics is essential for enhancing drug design methodologies, potentially leading to more effective targeted therapies.
The ongoing conflict in the Middle East has not yet caused significant disruptions to pharmaceutical supply chains, but future risks remain as the situation evolves. Pfizer is advancing its Lyme vaccine amidst these uncertainties.
A proposed bill in Maryland mandates that pharmaceutical companies and patient organizations disclose their affiliations with disease awareness campaigns, aiming to improve transparency.
Johnson & Johnson's newly approved oral psoriasis medication could reshape treatment paradigms, offering comparable efficacy to injectables and influencing market dynamics.
The White House is increasing its efforts to secure drug pricing reforms in Congress, focusing on a 'most-favored nation' policy that could reshape pharmaceutical pricing structures.
The recent price hikes by GSK on asthma inhalers have led to significant financial burdens and treatment accessibility issues for patients, as highlighted by a senator's report.
A recent trial by Structure Therapeutics indicates a significant weight loss of 16% in patients using their daily obesity pill over 44 weeks, suggesting potential shifts in obesity treatment strategies.
Recent research indicates that common crops, including tomatoes, carrots, and lettuce, can absorb trace pharmaceuticals from treated wastewater, raising concerns about food safety.
Farmers in drought-affected regions may leverage treated wastewater for irrigation, with specific crops shown to absorb pharmaceutical byproducts, addressing safety concerns.
Researchers at the University of Cambridge have introduced a novel approach to modifying complex drug molecules using light, potentially transforming drug design and manufacturing processes.
This analysis explores the operational strategies drug manufacturers and distributors can adopt to bolster supply chain resilience in the face of tariffs and disruptions.
Recent research has uncovered additional functions of the cereblon protein, a key player in cancer drug development, potentially improving existing therapies.
Servier has announced its acquisition of Day One Biopharmaceuticals, a company specializing in pediatric cancer treatments, for approximately $2.5 billion.